TABLE AT Heactoy ond Coat
‘rclge Specimen 5 Units Conrail Units
Activated cloting time WB 70-180 seconds 70-180 seconds
Activated protein C resistance (Factor V_ P ‘Not applicable Ratio > 2.1
Leiden)
Alpha; antiplasmin P 080-1.30 80-1308
Antihospiipid antibody pane
PTT-LA (lupus anticoagulant sereen) P Negative Negative
Platelet newtralization procedure P Negative Negative
Dilute viper venom sreen P Negative Negative
Antiarilpin antibody s
1G 0-15 abitary units 0-15 OPL
iM (0-15 aitray units 0-15 MPL
Anthro P
Antigenic 220-390 mel. 22-39 mei
Functional 08-130 UL 80-130%
‘Ant-Xa assay (Heparin assay) P
‘Unatonated heparin 03-07 AU 03-007 IU).
‘Low-molecula-Neight heparin 03-10 KUL 05-10 Unt.
Danaparod (Orgran) 05-08 KUL 05-08 1UimL.
Bieeing tim (adult) 2-95 min 2-95 min
Bone Marrow: see Tale B3
Cabosyhenoghbia we
‘Nonsmoker 0-003
Smoker (021-0042
‘Cot retraction WB 080-1,02h
Cryofibrinogen P Negative
Dimer P <05 mg
Differential blood count WB
‘Neutrophils 040-070 40-70%
Bands 00-0110 0-10%
Lympcyen 022-04 2-H
004-01 41%
Eosinophil 00-08 0.8%
Basophils 00-003 0-%%
Enythrocyte count WB
‘Adult males 490-590 X 104 480-590 X 10mm?
Adult females 400-5.20 X 10%. 4.00-5.20 X 104mm?
Enythreyt lifespan WB
‘Normal survival 120 days 120 days
(Chromium labeled aie (9) 25-35 cays, 25-35 dys
Exythrocyte sedimentation rate WB
Females 1-25 mh 1-25 mma
Males 0-17 mah 0-17 mhGtacone 6 phosphate dehydrogenase
(erythrocyte)
‘Hea’s test (ei serum)
Male (adil)
Female at)
Methomostobin |
‘Osmotic fragility of erythrocytes
Partial thromboplastin ime, activated
Plasminogen
Antigen
Panctional
Plasminogen activator inhibitor 1
Plaelet aggsezation
Pltcet count
Platelet, mean volume
Prokallibrein assay
Prokllibeinsereen
Protein C
‘Total antigen
Functional
Protein §
‘Total antigen
Functional
Free antigen
‘Protirombin gene mutation G20210A
Prothrombin tine
070-140
070-140
070-140
[Not applicsble
MBAs
028 064 pmol. of
‘blood ells
otis-0.45)
0-140
60-1408
130%
50-20%
00-140%
01308
140%
[No detuicney detected
0.3 Bethesda Units
20-200 ng/ml.
10-200 ng.
<2 agin.
150400 mgt.
MA17S ngat.
22 0 mefml-
$2.2 nga,
>175 neh,
[No gross doiciency
Negative
16-190 mest.
410-30
oan,
1-5 mail,
133-175 pat
120-160 gL
95-95%
15-35%
0208
‘Absent
Negative
0-12 pmol.
30-160 pl.
228428 weld.
13-139/100 neutrophils
45-110 x 10%
260-3800 pele
310-370 gall.
78-100 pn?
6102 jm?
Upto 1% of total hemoglobin
Increased hemolysis as compared to normal contrat
221-381
84-140 mesa.
80-1305"
443 ng.
65% aggrepation in response to adenosine diosphate,
“epinephrine, collagen, fstoetn, and arachidonic 1d
150-380 % 10m?
64-110 pn?
0-140%
[No deficiency detected
70-1308
70-140%
70-140%
70-150%
30 140%
Not
MA
16 36 wah. of red Wood cells
suseTABLE A-1—(Cntinaet)
‘Analyte Specinen 51 Units ventional Units
Reptilas time PB 10-245. 19-245
Reticuloeyte count WB 01005-0025 red cells 0.5-2.54% red cells
Reticulocyte hemoglobin content WB ——_->26pgkell >26 pplell
Ristocetin eanfactor (Functional von P
‘Willebrand factor)
Blood group 0 (075 mean of normal 75% mean of normal
Blood group A 1.05 mean of normal 105% mean of normal
Blood group B 1L15 mean of normal 115% mean of normal
Blood group AR 198 mean of normal 129% mean of normal
Schilling test, orally administered vitamin. =U Not applicable TH
By, excreted in urine
Sickle cell test WB Newatve Negative
Sucrose hemolysis we <0 -<10% hemolysis
‘Thrombin ime P 16-248 16-245
‘Total eosinophils WB 70-140 X 10%. 70-440/om'
“Transerin receptor SP 96-296 nmol 9.6-29.6 nmol/L.
Viscosity
Plasma P 17-21 17-21
Serum 8 118 11s.
Vitamin Bi SP
‘Normal 185 pmol. >250 pgm.
Borderline 92-185 pmol. 125-250 pgm.
Deficient <92 pmol. <125 pgm.
von Willebrand factor (¥WF) antigen P
(factor VIILR antigen)
{WF multimers P Normal distribution Normal distribution
White blood ells: oe Leukocytes
Not, pasa: PRP, platlesch plasma: S serum: U, wie; WB, whale blood
TABLE A-2nunolgy
‘Analte Specimen St Units Conventional Units
Autoantibodies
“Ant-adrenal antibody s Notapplicable Negative at 1:10 ition
Antidouble stranded (native) DNA s Not applicable Negative a 1:10 dition
‘Ant-glomerular basement membrane antibodies s
Oualitative Nesative Negative
Quantitative